Japan grants approval for GSK’s Duvroq to treat CKD-related anaemia
Japan's Ministry of Health, Labour and Welfare has granted the first regulatory approval for GlaxoSmithKline...
Read More...
Focus:
-
![Brazil covid-19 vaccine]()
Brazil signs $127m deal to manufacture Oxford Covid-19 vaccine
Brazil has entered an agreement worth $127m to manufacture a Covid-19 vaccine candidate which was...
Read More...
-
![Employee WFH COVID-19]()
Few employees want to return to office full-time when lockdowns are eased: Poll
Remote working or working from home has become the new norm during the COVID-19 times...
Read More...
-
![Samsung Bioepis]()
Samsung Bioepis secures positive CHMP opinion for Aybintio
Korean biopharmaceutical firm Samsung Bioepis has received a positive opinion from the Committee for Medicinal...
Read More...
-
![Daiichi Sankyo vaccine; Japan]()
Japan’s Daiichi Sankyo in talks with AstraZeneca for Covid-19 vaccine
Japanese pharmaceutical company Daiichi Sankyo has entered an agreement for discussions with AstraZeneca for the...
Read More...
-
![oxford university covid-19; Astrazeneca vaccine response]()
Oxford Covid-19 vaccine doses improve immune response in animals
A study conducted by the Pirbright Institute, in alliance with the University of Oxford, has...
Read More...
-
![NeuroRx]()
FDA grants fast track status to NeuroRx’s Covid-19 drug candidate
The US Food and Drug Administration (FDA) has granted fast track designation to RLF-100 (Aviptadil),...
Read More...
-
![vaccines consortium]()
UK researchers form consortium to monitor Covid-19 vaccines
The University of Dundee’s Medicines Monitoring Unity (MEMO Research) and the Drug Safety Research Unit...
Read More...
-
![Gilead remdesivir approval; Covid]()
Cipla and Hetero launch remdesivir to treat Covid-19 in India
India-based companies Cipla and Hetero have separately launched remdesivir, which has been licensed from Gilead...
Read More...
-
![Dupixent approval]()
Sanofi-Regeneron Dupixent secures China approval for atopic dermatitis
Sanofi and Regeneron Pharmaceuticals' Dupixent (dupilumab) has received approval from China's National Medical Products Administration...
Read More...
